Swissfinity is a European investment group, dedicated to the advanced biotech sector, specializing in the field of cell and gene therapy and enabling technologies.
Beyond providing capital, we offer strategic advisory and consultancy services to our portfolio and partner companies. Our team comprises seasoned professionals with over 150 years of combined interdisciplinary excellence. We leverage our business experience and global network to build strong investment portfolios and to provide tailored solutions in consulting for:
• M&A processes,
• management transition and restructuring,
• as well as business development and market strategy.
At Swissfinity Group we support the cure. Our mission is to empower companies with great ideas to further drive life sciences and healthcare innovation.
Company Details
- Employees
- 3
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.swissfinity-group.com
Swissfinity Group Questions
Swissfinity Group's website is http://www.swissfinity-group.com
Swissfinity Group's LinkedIn profile is https://www.linkedin.com/company/swissfinity-group
Swissfinity Group has
3 employees.
View email and phone details for 3
employees at Swissfinity Group.
Swissfinity Group's industry is
Biotechnology Research
Swissfinity Group's top competitors are
Cellex Cell Professionals,
Gemoab Gmbh,
Miltenyi Biotec,
Azenta Life Sciences,
Cellex - Cell Expansion Devices Srl,
Hypertrust,
Emily Whitehead Foundation,
Barkey Gmbh & Co. Kg,
Phacilitate,
Altius Bioventures.
Swissfinity Group's categories are Biotechnology Research
